April 26, 2011 2:42 pm by Frank Vinluan | 0 Comments
Pink eye drug AzaSite, a major component of Inspire Pharmaceutical‘s (NASDAQ:ISPH) portfolio and one of the key products sought by Merck (NYSE:MRK) in its $430 million acquisition of the North ...
Read more